Meeting your patients’ clinical needs is always your primary goal.
The Fenwal Amicus Gentle Science design delivers precision with
the high efficiency you've come to expect.
Every MNC collection is different. Because every patient and
donor is different. Fenwal Amicus is designed to make it easy to
tailor collections for high product purity or high MNC yield.
Fenwal Amicus lets you quickly and easily set your MNC protocol for a fine-tuned
therapeutic harvest. Wide for high yield, or narrow for high purity.
One therapeutic procedure shouldn’t result in the need for another one. The Gentle Science design of Fenwal Amicus keeps platelet loss at 20%1, so you can perform MNC procedures with reduced need for associated platelet transfusions on patients and donors with low platelet counts.2, 3WATCH HOW AMICUS SEPARATES MNCs
Meeting every patient’s clinical needs is always your primary goal. The Fenwal Amicus Gentle Science design delivers precision
you've come to expect—even for patients with lower blood volume.
Fenwal Amicus is designed to allow operators to set a maximum anticoagulant return rate that is most appropriate to your patient, reducing the risk of citrate reactions.DOWNLOAD TPE PRODUCT SHEET
Keeping patients comfortable is key to the care you provide. With
a high-accuracy, real-time volume measurement approach and a
low-volume extracorporeal kit, the Gentle Science design of
Fenwal Amicus runs smoothly even for your patients with lower blood volume.
Amicus RBCX accurately removes the patient's red blood cells (RBCs) while simultaneously infusing healthy donor cells. The clinical data demonstrates the system’s ability to successfully reach a target hematocrit (Hct), fraction of cells remaining (FCR), and reduction of hemoglobin S (HbS)7.DOWNLOAD RBCX BROCHURE
Amicus employs a kit design with an extracorporeal volume (ECV) of 160 mL. For patients with lower total blood volume, or lower hematocrit, Amicus offers a custom prime option (either partial or full). The partial prime option has the ability to mix saline with the prime source fluid to achieve a desired hematocrit in the return line.5